Astrazeneca plc (AZN) RNS Announcements

Date	Time	Date	TitleTitle (filtered)	Source
06/05/14	08:01:48	6 May 2014	US FDA APPROVES EPANOVA	US FDA APPROVES EPANOVA	RNS
02/05/14	12:00:02	2 May 2014	Rule 2.10 Announcement	Rule 2.10 Announcement	RNS
02/05/14	11:50:05	2 May 2014	ASTRAZENECA BOARD REJECTS PFIZER PROPOSAL	ASTRAZENECA BOARD REJECTS PFIZER PROPOSAL	RNS
02/05/14	09:09:02	2 May 2014	STATEMENT REGARDING PFIZER ANNOUNCEMENT	STATEMENT REGARDING PFIZER ANNOUNCEMENT	RNS
01/05/14	12:00:05	1 May 2014	Rule 2.10 Announcement	Rule 2.10 Announcement	RNS
01/05/14	12:00:04	1 May 2014	Total Voting Rights	Total Voting Rights	RNS
30/04/14	12:00:01	30 Apr 2014	Rule 2.10 Announcement	Rule 2.10 Announcement	RNS
29/04/14	17:30:03	29 Apr 2014	Rule 2.10 Announcement	Rule 2.10 Announcement	RNS
28/04/14	11:35:52	28 Apr 2014	Statement Regarding Pfizer Announcement	Statement Regarding Pfizer Announcement	RNS
24/04/14	18:20:04	24 Apr 2014	Result of AGM	Result of AGM	RNS
24/04/14	08:08:20	24 Apr 2014	1st Quarter Results - Part 2	1st Quarter Results - Part 2	RNS
24/04/14	08:08:10	24 Apr 2014	1st Quarter Results	1st Quarter Results	RNS
23/04/14	10:00:03	23 Apr 2014	Notice of Results	Notice of Results	RNS
01/04/14	15:00:04	1 Apr 2014	Director/PDMR Shareholding	Director/PDMR Shareholding	RNS
01/04/14	12:00:14	1 Apr 2014	Total Voting Rights	Total Voting Rights	RNS
31/03/14	15:00:04	31 Mar 2014	Director/PDMR Shareholding	Director/PDMR Shareholding	RNS
31/03/14	15:00:04	31 Mar 2014	Director/PDMR Shareholding	Director/PDMR Shareholding	RNS
31/03/14	15:00:04	31 Mar 2014	Director/PDMR Shareholding	Director/PDMR Shareholding	RNS
26/03/14	11:00:21	26 Mar 2014	Director/PDMR Shareholding	Director/PDMR Shareholding	RNS
21/03/14	07:00:14	21 Mar 2014	Filing of Annual Report on Form 20-F with SEC	Filing of Annual Report on Form 20-F with SEC	RNS
20/03/14	11:00:03	20 Mar 2014	Directorate Change	Directorate Change	RNS
20/03/14	11:00:03	20 Mar 2014	Annual Financial Report	Annual Financial Report	RNS
19/03/14	15:00:03	19 Mar 2014	Director/PDMR Shareholding	Director/PDMR Shareholding	RNS
12/03/14	07:00:34	12 Mar 2014	AstraZeneca announces sale of Alderley Park site	AstraZeneca announces sale of Alderley Park site	RNS
03/03/14	16:00:04	3 Mar 2014	Total Voting Rights	Total Voting Rights	RNS
03/03/14	07:00:25	3 Mar 2014	US FDA APPROVES BYDUREON® PEN	US FDA APPROVES BYDUREON® PEN	RNS
25/02/14	18:24:17	25 Feb 2014	FDA Approves Orphan Drug Myalept	FDA Approves Orphan Drug Myalept	RNS
12/02/14	15:30:07	12 Feb 2014	Director/PDMR Shareholding	Director/PDMR Shareholding	RNS
11/02/14	17:00:03	11 Feb 2014	Director/PDMR Shareholding	Director/PDMR Shareholding	RNS
10/02/14	17:30:02	10 Feb 2014	Director/PDMR Shareholding	Director/PDMR Shareholding	RNS
07/02/14	15:30:02	7 Feb 2014	Director/PDMR Shareholding	Director/PDMR Shareholding	RNS
06/02/14	07:00:39	6 Feb 2014	Pipeline Table	Pipeline Table	RNS
06/02/14	07:00:37	6 Feb 2014	Final Results	Final Results	RNS
05/02/14	09:00:02	5 Feb 2014	Notice of Results	Notice of Results	RNS
03/02/14	16:30:03	3 Feb 2014	Total Voting Rights	Total Voting Rights	RNS
03/02/14	07:00:16	3 Feb 2014	AZ completes BMS diabetes acquisition	AZ completes BMS diabetes acquisition	RNS
27/01/14	10:30:05	27 Jan 2014	Holding(s) in Company	Holding(s) in Company	RNS
22/01/14	07:00:11	22 Jan 2014	Xigduo approved in EU for type 2 diabetes	Xigduo approved in EU for type 2 diabetes	RNS
17/01/14	10:42:09	17 Jan 2014	Replacement re block listing application	Replacement re block listing application	RNS
17/01/14	07:00:09	17 Jan 2014	Block Listing Application	Block Listing Application	RNS
14/01/14	07:00:21	14 Jan 2014	AstraZeneca provides strategy update at JP Morgan	AstraZeneca provides strategy update at JP Morgan	RNS
13/01/14	07:00:08	13 Jan 2014	US FDA APPROVES FARXIGAT (DAPAGLIFLOZIN)	US FDA APPROVES FARXIGAT (DAPAGLIFLOZIN)	RNS
09/01/14	07:00:09	9 Jan 2014	US FDA Approval of Farxiga (dapagliflozin)	US FDA Approval of Farxiga (dapagliflozin)	RNS
02/01/14	16:00:07	2 Jan 2014	Total Voting Rights	Total Voting Rights	RNS
27/12/13	07:13:59	27 Dec 2013	AZ and Shionogi extend Crestor agreement	AZ and Shionogi extend Crestor agreement	RNS
19/12/13	14:00:02	19 Dec 2013	Director/PDMR Shareholding	Director/PDMR Shareholding	RNS
19/12/13	07:50:29	19 Dec 2013	AZ to acquire BMS share of diabetes assets	AZ to acquire BMS share of diabetes assets	RNS
17/12/13	18:13:17	17 Dec 2013	STATEMENT ON ESOMEPRAZOLE STRONTIUM LAUNCH IN US	STATEMENT ON ESOMEPRAZOLE STRONTIUM LAUNCH IN US	RNS
13/12/13	07:14:59	13 Dec 2013	Top Line Results From Phase III Study of Lesinurad	Top Line Results From Phase III Study of Lesinurad	RNS
13/12/13	07:00:10	13 Dec 2013	FDA Advisory Committee Recommends Dapagliflozin	FDA Advisory Committee Recommends Dapagliflozin	RNS

Showing 1301–1350 of 1,436 announcements

Astrazeneca plc RNS

Astrazeneca plc RNS